Kitasato University Hospital worked on a doctor-led midstage clinical trial, the results of which are not yet available. Kowa Co. has recently launched a final-phase clinical trial. The Tokyo Medical Association has also extended its support to Kowa’s trial. At the height of Japan’s fifth wave in mid-August, its president, Haruo Ozaki, proposed the emergency use of ivermectin to deal effectively with the pandemic. “Although an examination is necessary by conducting a clinical trial properly, under a strained situation like this, I think we’ve reached a stage where it’s OK to have the authorization issued to use ivermectin on patients after getting their informed consent,” he told reporters on Aug. 13.
If this is the one, it will not complete until May 31, 2022:
https://clinicaltrials.gov/ct2/show/results/NCT04703205
So, looks like we’ll have to keep checking on it.